Page last updated: 2024-08-23

daunorubicin and B-Cell Leukemia

daunorubicin has been researched along with B-Cell Leukemia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elloumi, M; Haddar, S; Hentati, Y; Kammoun, F; Kridis, WB; Mahfoudh, KB; Mdhaffer, M; Milad, A; Triki, C1
Devidas, M; Gaynon, PS; Hastings, C; Lu, X; Nachman, JB; Sather, HN; Seibel, NL1
Codeluppi, M; Ferrari, A; Guaraldi, G; Imovilli, A; Luppi, M; Morselli, M; Potenza, L; Riva, G; Rossi, G; Torelli, G; Volzone, F1
Hählen, K; Huismans, DR; Loonen, AH; Peters, GJ; Pieters, R; van der Does-van den Berg, A; van Wering, ER; Veerman, AJ1
Caballero, MD; Cañizo, MC; González, M; Nieto, MJ; Orfao, A; San Miguel, JF1

Trials

1 trial(s) available for daunorubicin and B-Cell Leukemia

ArticleYear
Increased post-induction intensification improves outcome in children and adolescents with a markedly elevated white blood cell count (≥200 × 10(9) /l) with T cell acute lymphoblastic leukaemia but not B cell disease: a report from the Children's Oncology
    British journal of haematology, 2015, Volume: 168, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cranial Irradiation; Cyclophosphamide; Daunorubicin; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Female; Follow-Up Studies; Humans; Idarubicin; Infant; Kaplan-Meier Estimate; Leukemia, B-Cell; Leukocyte Count; Leukocytosis; Male; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Risk; Treatment Outcome; Vincristine

2015

Other Studies

4 other study(ies) available for daunorubicin and B-Cell Leukemia

ArticleYear
Posterior reversible encephalopathy syndrome in leukemic children: a sensitive issue.
    Current drug safety, 2015, Volume: 10, Issue:2

    Topics: Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Brain Edema; Child; Daunorubicin; Dexamethasone; Electroencephalography; Glasgow Outcome Scale; Humans; Leukemia, B-Cell; Magnetic Resonance Imaging; Male; Neurologic Examination; Posterior Leukoencephalopathy Syndrome; Vincristine

2015
Herpes simplex virus pneumonia during standard induction chemotherapy for acute leukemia: case report and review of literature.
    Leukemia, 2005, Volume: 19, Issue:11

    Topics: Acyclovir; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Daunorubicin; Female; Herpes Simplex; Humans; Leukemia, B-Cell; Middle Aged; Pneumonia, Viral; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Simplexvirus; Vincristine

2005
Relation of 5'-nucleotidase and phosphatase activities with immunophenotype, drug resistance and clinical prognosis in childhood leukemia.
    Leukemia research, 1992, Volume: 16, Issue:9

    Topics: 5'-Nucleotidase; Acid Phosphatase; Adolescent; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin; Drug Resistance; Female; Humans; Immunophenotyping; Infant; Leukemia, B-Cell; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Vincristine

1992
Concomitant chronic lymphocytic leukemia (CLL) and acute myeloid leukemia. Complete remission of CLL achieved with high-dose cytosine arabinoside.
    Leukemia, 1992, Volume: 6, Issue:8

    Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Leukemia, B-Cell; Leukemia, Myeloid; Middle Aged; Neoplasms, Multiple Primary; Remission Induction

1992